| 8524697 |
C20-C21 substituted glucocorticoid receptor agonists |
John C. Anthes, Kevin D. McCormick, John Hey, Robert G. Aslanian, Purakkattle Biju +5 more |
2013-09-03 |
$73,082,000 |
| 7879880 |
Substituted aniline derivatives useful as histamine H3 antagonists |
Robert G. Aslanian, Michael Y. Berlin, Manuel de Lera Ruiz, Kevin D. McCormick, Mwangi W. Mutahi +1 more |
2011-02-01 |
|
| 7846946 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz +9 more |
2010-12-07 |
|
| 7638531 |
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists |
Mwangi W. Mutahi, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Manuel de Lera Ruiz +7 more |
2009-12-29 |
|
| 7635705 |
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists |
Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Chao, Manuel de Lera Ruiz +9 more |
2009-12-22 |
|
| 7238688 |
Piperidine compounds |
Stuart B. Rosenblum, Qingbei Zeng, Mwangi W. Mutahi, Robert G. Aslanian, Pauline C. Ting +6 more |
2007-07-03 |
$194,740,000 |
| 7220735 |
Benzimidazolone histamine H3 antagonists |
Pauline C. Ting, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao +7 more |
2007-05-22 |
$108,242,000 |
| 7105505 |
Benzimidazole derivatives useful as histamine H3 antagonists |
Qingbei Zeng, Robert G. Aslanian, Michael Y. Berlin, Christopher W. Boyce, Jianhua Cao +7 more |
2006-09-12 |
$71,279,000 |
| 6849621 |
Piperidine compounds |
Stuart B. Rosenblum, Qingbei Zeng, Mwangi W. Mutahi, Robert G. Aslanian, Pauline C. Ting +6 more |
2005-02-01 |
|
| 6762186 |
Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
Neng-Yang Shih, Robert G. Aslanian, Stuart B. Rosenblum, Mwangi W. Mutahi, Tom G. Wing +3 more |
2004-07-13 |
$81,915,000 |
| 6506756 |
Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
Neng-Yang Shih, John J. Piwinski, Andrew T. Lupo, Jr., Michael J. Green |
2003-01-14 |
$151,779,000 |
| 6211182 |
Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms |
Wayne Vaccaro, John J. Piwinski, Wing C. Tom, Robert G. Aslanian |
2001-04-03 |
$204,559,000 |
| 6100279 |
Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
Wayne Vaccaro, Ronald L. Wolin, Robert G. Aslanian, John J. Piwinski, Stuart B. Rosenblum |
2000-08-08 |
$183,794,000 |
| 5939431 |
Naphthyridines which affect IL-4 and G-CSF |
Michael J. Grace, Jay Fine, Loretta A. Bober, Margaret H. Sherlock |
1999-08-17 |
$137,934,000 |
| 5767120 |
Tricyclic derivatives, compositions and methods of use |
Pauline C. Ting, Richard J. Friary, John J. Piwinski, Joe F. Lee, Vera A. Seidl +1 more |
1998-06-16 |
$112,117,000 |
| 5688805 |
Tricyclic derivatives, compositions and methods of use |
Pauline C. Ting, Wing C. Tom, Steven K. White, James J. Kaminski, Shing-Chun Wong +1 more |
1997-11-18 |
$46,204,000 |
| 5538986 |
Tricyclic derivatives, compositions and methods of use |
Pauline C. Ting, Richard J. Friary, Frank J. Villani, John J. Piwinski, Joe F. Lee +1 more |
1996-07-23 |
$32,253,000 |
| 5464840 |
Tricyclic derivatives, compositions and methods of use |
Pauline C. Ting, Wing C. Tom |
1995-11-07 |
$44,924,000 |
| 5449680 |
2,2 disubstituted glycerol and glycerol-like compounds, compositions and methods of use |
James J. Kaminski, Steven K. White, Laura S. Lehman de Gaeta, Ashit K. Ganguly |
1995-09-12 |
$24,211,000 |
| 5185334 |
2,2-disubstituted glycerol and glycerol-like compounds, compositions and methods of use |
James J. Kaminski, Steven K. White, Laura S. Lehman de Gaeta, Ashit K. Ganguly |
1993-02-09 |
$71,608,000 |
| 4847377 |
Substituted-2,3-dihydro-6-substituted-pyrimido[2,1-F]-purine- 4,8(1H,9H)-diones |
James J. Kaminski, David J. Conn |
1989-07-11 |
$9,944,000 |
| 4816458 |
Method of treating hyperploliferative skin disease with substituted-2,3-dihydro-6-substituted -pyrimido[2,1]-purine-4,8(1H,9H)diones |
James J. Kaminski |
1989-03-28 |
$31,050,000 |
| 4666914 |
Anti-inflammatory and anti-allergic substituted-2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]-purine-4,8(1H,9H)-dio nes |
James J. Kaminski, David J. Conn |
1987-05-19 |
$14,291,000 |
| 4196124 |
1-Benzhydryl-2-benzimidoyl-azetidine |
Elijah H. Gold |
1980-04-01 |
$10,264,000 |
| 4183923 |
Antipsoriatic compositions |
Elijah H. Gold |
1980-01-15 |
$7,101,000 |
